ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 58 filers reported holding ADC THERAPEUTICS SA in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $763,111 | -59.9% | 850,737 | -3.9% | 0.51% | -53.2% |
Q2 2023 | $1,903,868 | -17.7% | 885,520 | -25.3% | 1.10% | -16.6% |
Q1 2023 | $2,313,119 | -49.2% | 1,186,215 | 0.0% | 1.31% | -51.2% |
Q4 2022 | $4,555,066 | -20.3% | 1,186,215 | 0.0% | 2.69% | -19.5% |
Q3 2022 | $5,718,000 | -39.4% | 1,186,215 | 0.0% | 3.34% | -36.8% |
Q2 2022 | $9,430,000 | -61.8% | 1,186,215 | -29.4% | 5.29% | -45.1% |
Q1 2022 | $24,681,000 | -27.3% | 1,680,149 | 0.0% | 9.63% | +5.5% |
Q4 2021 | $33,939,000 | -25.6% | 1,680,149 | 0.0% | 9.12% | -6.6% |
Q3 2021 | $45,633,000 | +11.5% | 1,680,149 | 0.0% | 9.77% | +37.3% |
Q2 2021 | $40,911,000 | -0.2% | 1,680,149 | 0.0% | 7.12% | -13.6% |
Q1 2021 | $41,012,000 | -23.7% | 1,680,149 | 0.0% | 8.23% | +88.0% |
Q4 2020 | $53,782,000 | – | 1,680,149 | – | 4.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |